Shree Ganesh Bio-Tech (India) Ltd

NSE: SHREEGANES · BSE: 539470 · Pharmaceuticals & Biotechnology · 12 announcements

Share price: ₹0.47
Market cap: ₹18.74 Cr
Revenue (annual): ₹4.97 Cr
Net profit (annual): ₹0.38 Cr
P/E (TTM): -48.5×Sector 47.4×
Promoter holding: 0.00%+0.00% QoQ
FII holding: 1.42%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Other Announcement 3 Board Meeting Date 2 Debt & Borrowing 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

4 announcements with these filters

4 Aug 2026 16:16 IST BSE

Financial Results

Shree Ganesh Bio-Tech (India) Q1 FY27 Results: Net Loss of ₹0.6 Cr

Shree Ganesh Bio-Tech (India) Ltd reported revenue from operations of ₹1.4 Cr (+0.0% YoY) and a net loss of ₹0.6 Cr for Q1 FY27.

Key figure: Net loss ₹0.6 Cr

Open full results → Read the filing ↗

14 May 2026 17:38 IST BSE

Financial Results

Shree Ganesh Bio-Tech (India) Q4 FY26 Results: Net Loss of ₹0.1 Cr, Loss Narrows

Shree Ganesh Bio-Tech (India) Ltd reported revenue from operations of ₹2.1 Cr (-30.0% YoY) and a net loss of ₹0.1 Cr for Q4 FY26.

Key figure: Net loss ₹0.1 Cr

Open full results → Read the filing ↗

14 May 2026 17:37 IST BSE

Financial Results

Shree Ganesh Bio-Tech (India) Financial Results

Shree Ganesh Biotech (India) Ltd reported annual revenue of ₹4.97 Crore for FY2026. The board approved audited results with an unmodified audit opinion.

Value: ₹4.97 Cr

Read the filing ↗

8 Apr 2026 22:58 IST BSE

Financial Results

Shree Ganesh Bio-Tech (India) Q3 FY26 Results: Net Profit ₹0.3 Cr, Down 62.5% YoY

Shree Ganesh Bio-Tech (India) Ltd reported net profit of ₹0.3 Cr (-62.5% YoY) for Q3 FY26.

Key figure: Net profit ₹0.3 Cr · -62.5% YoY

Open full results → Read the filing ↗